BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 25900239)

  • 1. PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.
    Li Z; Ling ZQ; Guo W; Lu XX; Pan Y; Wang Z; Chen Y
    Oncotarget; 2015 May; 6(14):12357-68. PubMed ID: 25900239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-15b facilitates breast cancer progression via repressing tumor suppressor PAQR3.
    Qi LQ; Sun B; Yang BB; Lu S
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):740-748. PubMed ID: 32016977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis.
    Chen J; Wang F; Xu J; He Z; Lu Y; Wang Z
    Oncol Rep; 2016 Sep; 36(3):1612-8. PubMed ID: 27461225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of MIIP regulates human breast cancer proliferation, invasion and migration by mediated by IGFBP2.
    Du Y; Wang P
    Pathol Res Pract; 2019 Jul; 215(7):152440. PubMed ID: 31078343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
    Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
    Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Golgi-specific protein PAQR3 is closely associated with the progression, metastasis and prognosis of human gastric cancers.
    Ling ZQ; Guo W; Lu XX; Zhu X; Hong LL; Wang Z; Wang Z; Chen Y
    Ann Oncol; 2014 Jul; 25(7):1363-1372. PubMed ID: 24799462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin receptor expression and its relationship with trastuzumab response and resistance in HER2-positive breast cancer cells.
    Zhang C; Duan X; Xu L; Ye J; Zhao J; Liu Y
    Breast Cancer Res Treat; 2012 Dec; 136(3):739-48. PubMed ID: 23117856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAQR3 inhibits the proliferation, migration and invasion in human glioma cells.
    Tang SL; Gao YL; Hu WZ
    Biomed Pharmacother; 2017 Aug; 92():24-32. PubMed ID: 28528182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAQR3 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer Cells.
    Zhou F; Wang S; Wang J
    Oncol Res; 2017 May; 25(5):663-671. PubMed ID: 28548040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor suppressor role of PAQR3 in osteosarcoma.
    Ma Z; Wang Y; Piao T; Li Z; Zhang H; Liu Z; Liu J
    Tumour Biol; 2015 May; 36(5):3319-24. PubMed ID: 25510670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
    Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.
    Seachrist DD; Sizemore ST; Johnson E; Abdul-Karim FW; Weber Bonk KL; Keri RA
    Breast Cancer Res; 2017 Jun; 19(1):66. PubMed ID: 28583174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer].
    Liang X; Sun B; Han J; Zhao X; Liu Z
    Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):259-263. PubMed ID: 28442015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Erbin in Her2-overexpressing breast cancer cells promotes cell migration and induces trastuzumab resistance.
    Liu D; Shi M; Duan C; Chen H; Hu Y; Yang Z; Duan H; Guo N
    Mol Immunol; 2013 Nov; 56(1-2):104-12. PubMed ID: 23711387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-130a inhibits cell proliferation, invasion and migration in human breast cancer by targeting the RAB5A.
    Pan Y; Wang R; Zhang F; Chen Y; Lv Q; Long G; Yang K
    Int J Clin Exp Pathol; 2015; 8(1):384-93. PubMed ID: 25755726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
    Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
    Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PAQR3 inhibits proliferation and aggravates ferroptosis in acute lymphoblastic leukemia through modulation Nrf2 stability.
    Jin L; Tong L
    Immun Inflamm Dis; 2021 Sep; 9(3):827-839. PubMed ID: 33955706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endophilin A2 promotes HER2 internalization and sensitivity to trastuzumab-based therapy in HER2-positive breast cancers.
    Baldassarre T; Truesdell P; Craig AW
    Breast Cancer Res; 2017 Oct; 19(1):110. PubMed ID: 28974266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDB2 is involved in ubiquitination and degradation of PAQR3 and regulates tumorigenesis of gastric cancer cells.
    Qiao S; Guo W; Liao L; Wang L; Wang Z; Zhang R; Xu D; Zhang Y; Pan Y; Wang Z; Chen Y
    Biochem J; 2015 Aug; 469(3):469-80. PubMed ID: 26205499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
    Bai G; Chu J; Eli M; Bao Y; Wen H
    Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.